CALCIUM DISODIUM VERSENATE
LOE ApproachingNDAINJECTIONINJECTABLEPriority Review
Approved
Jul 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 22h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Calcium Disodium Versenate is an injectable chelating agent approved in 1953 for treating heavy metal poisoning, particularly lead toxicity. It works by binding to metal ions and facilitating their urinary excretion. This is a legacy product with well-established clinical utility in acute and chronic metal poisoning management.
LOE Approaching
This is a niche product approaching loss of exclusivity with minimal linked job openings, suggesting a small, stable team focused on maintenance rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Calcium Disodium Versenate offers stability in a legacy product with specialized clinical knowledge but limited career growth opportunities. This role is best suited for professionals seeking deep expertise in rare/niche therapeutics or transition/legacy management experience.
Brand ManagerMedical Science Liaison
Worked on CALCIUM DISODIUM VERSENATE at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.